Trump secures drug pricing deals with 9 pharma firms, bringing total to 26

scanx
Reviewed by
Shraddha JScanX News Team
Key Highlights
  • Trump administration secures drug pricing deals with 9 new pharma firms, bringing total to 26 companies
  • These 26 firms represent 90% of the US pharmaceutical market, according to President Trump
  • New signatories commit to $19.6 billion in US manufacturing investment and Medicaid discounts
  • White House estimates potential savings of $529 billion for the economy over the next decade
powered bylight_fuzz_icon
49749817

*this image is generated using AI for illustrative purposes only.

President Donald Trump secured new drug pricing agreements with nine pharmaceutical companies, expanding the administration's total deals to 26 firms. These entities now represent 90% of the US pharmaceutical market, according to the President.

New agreements and commitments

The nine new signatories include Alcon Inc., Astellas Pharma, BeOne Medicines Ltd., BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals Industries Ltd., and UCB. The deals require these companies to offer discounts on outpatient drugs across all state Medicaid programs, aiming to align US prices with international markets.

Beyond pricing, the companies committed to collectively investing at least $19.6 billion in US manufacturing in the near term. Astellas, Sun Pharma, Teva, and UCB also agreed to donate active pharmaceutical ingredients for key medicines to the federal government’s strategic reserve.

Metric Detail
Total companies in deals 26
Market share represented 90%
New manufacturing investment $19.6 billion
Key new signatories Alcon, Astellas, Teva, Sun Pharma, UCB

Market concentration and policy context

These agreements build on 17 previous deals struck over the past year with firms including Pfizer Inc., Eli Lilly And Co, and Novo Nordisk A/S. The policy aims to reduce exposure to tariffs by shifting manufacturing to the US while lowering costs through direct-to-consumer platforms like TrumpRx.

White House economists estimated in May that these pricing deals could lead to savings of $529 billion for the economy over the next decade. Additionally, federal and state governments could save $64.3 billion on Medicaid due to the "most favored nation" policy on drug prices.

What the Numbers Show

The consolidation of 90% of the market into just 26 agreements highlights the high degree of concentration in the US pharmaceutical sector. While the $19.6 billion manufacturing commitment signals a shift in supply chain geography, the requirement for Medicaid discounts directly pressures revenue streams, as noted by Novo Nordisk’s expectation that higher prescription volumes will take time to offset price declines.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How will the mandated Medicaid discounts impact the R&D budgets and future pipeline innovation of the 26 signatory pharmaceutical companies?

What are the potential supply chain risks or delays associated with shifting $19.6 billion in manufacturing capacity to the US in the near term?

Could the 'most favored nation' pricing model trigger retaliatory trade measures or regulatory hurdles for US pharma exports in international markets?

like18
dislike

Trump defends data centers; Greene mocks stance

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Trump defends data centers, warning opposition helps China
  • Greene mocks stance, citing land/water use and job concerns
  • Sanders cites 75% public opposition to local facilities
  • Fetterman backs Trump on AI supremacy over China
  • US leads globally with 4,423 data centers as of April 2026
powered bylight_fuzz_icon
49772850

*this image is generated using AI for illustrative purposes only.

President Donald Trump defended the expansion of AI data centers on Monday, arguing that opposition risks economic stagnation. Former Congresswoman Marjorie Taylor Greene mocked the position, suggesting it could harm Republican midterm prospects.

Trump Defends AI Data Centers as Backlash Grows

In a Truth Social post, Trump argued that communities opposing data centers risk becoming backward and poor. He stated that embracing these facilities could bring jobs, investment, and lower taxes.

"If they want to be successful and rich, with far lower taxes and jobs all over the place, let Data Reign," Trump wrote. He warned that blocking projects could benefit China, adding that the country "could not be happier" about the growing anti-data-center movement.

Trump further cautioned: "If we kill the Golden Goose, you will only have yourselves to blame."

Marjorie Taylor Greene Fires Back at Trump

Greene criticized the president’s argument, noting that Americans are increasingly attending local government meetings to oppose data-center projects. She accused the facilities of consuming land and water, creating noise pollution, and producing relatively few permanent jobs after construction.

"If Trump wants data centers build them on all his golf courses and country clubs and right in the backyard at Mar-a-Lago!!" Greene wrote on X.

She concluded with a warning: "Good luck winning the midterms now."

Data Center Backlash Becomes Bipartisan

Sen. Bernie Sanders (I-Vt.) rejected Trump’s characterization of opponents. He argued they want a better future for their communities and are concerned about energy use, privacy, jobs, children’s mental health, and the broader impact of AI.

"No, Mr. President, the 75% of Americans who oppose data centers in their communities do not want to be ‘backwards and poor,’" Sanders wrote. "They have every right to be concerned."

Meanwhile, Sen. John Fetterman (D-Pa.) agreed with Trump’s pro-data-center stance. He said the U.S. must "win the war for AI supremacy over China." Fetterman noted that misinformation fuels the anti-argument, stating, "There’s nothing more damaging to a Democrat than agreeing with Trump AND data centers—but what’s right is right."

CNBC’s Jim Cramer warned that companies could move projects to Mexico if the U.S. makes development too difficult. He highlighted Queretaro, where Amazon is building a facility, as a potential beneficiary.

Data Center Backlash Grows Nationwide

Public opposition remains high. A Gallup survey found 71% of Americans oppose building an AI data center in their area, with 48% strongly opposed. Concerns include electricity costs, water consumption, land use, and environmental impacts.

Texas has ordered an audit of data centers, while New York has paused certain large projects amid grid concerns. According to Statista, the U.S. had 4,423 data centers as of April 14, 2026, the highest number worldwide. The U.K. followed with 555 facilities, while Germany had 523.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might the threat of companies relocating AI infrastructure to Mexico impact U.S. competitiveness in the global race for AI supremacy?

What specific regulatory measures are states like Texas and New York likely to implement next to balance data center growth with grid stability and resource constraints?

Could the bipartisan nature of the backlash lead to federal legislation that standardizes environmental and zoning requirements for data centers across the country?

like16
dislike